Aseptic Pharmaceutical Processing: It All Begins in The Lab
The drive towards novel drug presentation and injectable-grade products is generating increased demand for aseptic pharmaceutical processing, including aseptic spray-drying…
Read more
Label-free Cell-based Assay for Peptide-receptor Interaction Characterisation
Both the drug development process and fundamental studies of mechanisms underlying biological interactions require analytical methods that mimic the in…
Current Perspective on TBI
Dr Adrian Harel of Medicortex conveys the urgency of developing mitigating therapeutics for the secondary and long-term damaging effects of…
Ready for Battle: How Preclinical Development Brings New Vaccines to the War on Disease
Few medical advances have made as large an impact on world health as vaccines. Yet the battle isn’t over. As…
Regulatory Focus on Nanomedicines in US and Europe
Vidhya Sabbella, Valluru Ravi, T. M. Pramod Kumar and K. Sreekanth Reddy, of JSS College of Pharmacy, JSS University, Mysore,…
Outsourcing Computational Chemistry for Drug Discovery
Computational chemistry is a highly-skilled scientific field that has delivered proven results for drug discovery, particularly in the areas of…
Keeping Data Secure and Validated in the Cloud – Addressing the Misconceptions Surrounding Cloud Computing in Pharma
The requirement to demonstrate compliance, while still maintaining process efficiency and ease of use for marketing teams and time-to-market for…
Achieving Operational Excellence in Drug Safety with an Effective Quality Management System
The International Conference on Harmonisation (ICH), European Medicines Agency (EMA) and US Food and Drug Administration (US FDA) have laid…
Merging and Acquisition Perspective in Pharmaceutical Industry
It is very difficult to estimate how many mergers and acquisitions in the pharmaceutical industry have succeeded. It is even…
FDA Issues Guidance on Reporting Requirements for Web-Based Promotion of Drugs and Biologics
The FDA has finally given some guidance on what drug companies must do to comply with federal reporting requirements when…